Patterns of Marijuana Use and Nicotine Exposure in Patients Seeking Elective Aesthetic Procedures.
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
medline:
29
8
2024
pubmed:
29
8
2024
entrez:
28
8
2024
Statut:
ppublish
Résumé
With the increasing legalization and popularity of marijuana, it is frequently and sometimes unintentionally combined with nicotine-containing products. As a consequence, patients may fail to accurately report usage during preoperative examinations or remain unaware of the inclusion of nicotine. This poses a challenge for clinicians in identifying preoperative nicotine exposure. This study aimed to establish normative data on the use of marijuana and nicotine in plastic surgery patients and correlate it with urine nicotine and cotinine levels. All consecutive patients presenting to the authors' clinic seeking elective procedures were identified. Patients were surveyed on marijuana and nicotine use, and provided a urine sample for analysis. The survey responses, urine results, surgical treatments, and clinical outcomes were followed up prospectively. A total of 135 patients completed the survey and were categorized as nonusers (50%), active nicotine users (19%), active marijuana users (7%), active users of both (13%), or past users (11%). Marijuana users who denied nicotine use showed significantly elevated nicotine and cotinine levels compared with nonusers (average nicotine level, 23.1 ± 13.5 ng/mL [P = 0.00007]; average cotinine level, 221.2 ± 141.8 ng/mL [P = 0.0002]). Fewer than a third of active marijuana or nicotine users reported active use of these products during clinical encounters. There was no difference in urine levels, reported use, or other patient characteristics in patients with and without postoperative complications. This is the first descriptive study to document elevated urine nicotine levels in self-reported marijuana users in an urban, diverse patient population seeking elective plastic surgery procedures.
Sections du résumé
BACKGROUND
BACKGROUND
With the increasing legalization and popularity of marijuana, it is frequently and sometimes unintentionally combined with nicotine-containing products. As a consequence, patients may fail to accurately report usage during preoperative examinations or remain unaware of the inclusion of nicotine. This poses a challenge for clinicians in identifying preoperative nicotine exposure. This study aimed to establish normative data on the use of marijuana and nicotine in plastic surgery patients and correlate it with urine nicotine and cotinine levels.
METHODS
METHODS
All consecutive patients presenting to the authors' clinic seeking elective procedures were identified. Patients were surveyed on marijuana and nicotine use, and provided a urine sample for analysis. The survey responses, urine results, surgical treatments, and clinical outcomes were followed up prospectively.
RESULTS
RESULTS
A total of 135 patients completed the survey and were categorized as nonusers (50%), active nicotine users (19%), active marijuana users (7%), active users of both (13%), or past users (11%). Marijuana users who denied nicotine use showed significantly elevated nicotine and cotinine levels compared with nonusers (average nicotine level, 23.1 ± 13.5 ng/mL [P = 0.00007]; average cotinine level, 221.2 ± 141.8 ng/mL [P = 0.0002]). Fewer than a third of active marijuana or nicotine users reported active use of these products during clinical encounters. There was no difference in urine levels, reported use, or other patient characteristics in patients with and without postoperative complications.
CONCLUSION
CONCLUSIONS
This is the first descriptive study to document elevated urine nicotine levels in self-reported marijuana users in an urban, diverse patient population seeking elective plastic surgery procedures.
Identifiants
pubmed: 39196865
doi: 10.1097/PRS.0000000000011145
pii: 00006534-202409000-00019
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Cotinine
K5161X06LL
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
478e-485eInformations de copyright
Copyright © 2023 by the American Society of Plastic Surgeons.
Références
Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135:209–216.
Copeland-Halperin LR, Herrera-Gomez LC, LaPier JR, Shank N, Shin JH. The effects of cannabis: implications for the surgical patient. Plast Reconstr Surg Glob Open 2021;9:e3448.
Edalatpour A, Attaluri P, Larson JD. Medicinal and recreational marijuana: review of the literature and recommendations for the plastic surgeon. Plast Reconstr Surg Glob Open 2020;8:e2838.
Davis DR, Bold KW, Kong G, Cavallo DA, Jackson A, Krishnan-Sarin S. Cannabis use among youth who vape nicotine E-cigarettes: a qualitative analysis. Drug Alcohol Depend. 2022;234:109413.
Peters EN, Schauer GL, Rosenberry ZR, Pickworth WB. Does marijuana “blunt” smoking contribute to nicotine exposure? Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking. Drug Alcohol Depend. 2016;168:119–122.
Goltsman D, Munabi NCO, Ascherman JA. The Association between smoking and plastic surgery outcomes in 40,465 patients: an analysis of the American College of Surgeons national surgical quality improvement program data sets. Plast Reconstr Surg. 2017;139:503–511.
Silverstein P. Smoking and wound healing. Am J Med. 1992;93:S22–S24.
Rees TD, Liverett DM, Guy CL. The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg. 1984;73:911–915.
Coon D, Tuffaha S, Christensen J, Bonawitz SC. Plastic surgery and smoking: a prospective analysis of incidence, compliance, and complications. Plast Reconstr Surg. 2013;131:385–391.
Klifto KM, Shetty PN, Slavin BR, et al. Impact of nicotine/smoking, alcohol, and illicit substance use on outcomes and complications of burn patients requiring hospital admission: systematic review and meta-analysis. Burns 2020;46:1498–1524.
Theocharidis V, Katsaros I, Sgouromallis E, et al. Current evidence on the role of smoking in plastic surgery elective procedures: a systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2018;71:624–636.
Taub PJ, Matarasso A. E-cigarettes and potential implications for plastic surgery. Plast Reconstr Surg. 2016;138:1059e–1066e.
Fracol M, Dorfman R, Janes L, et al. The surgical impact of e-cigarettes: a case report and review of the current literature. Arch Plast Surg. 2017;44:477–481.
Payne CE, Southern SJ. Urinary point-of-care test for smoking in the pre-operative assessment of patients undergoing elective plastic surgery. J Plast Reconstr Aesthet Surg. 2006;59:1156–1161.
Lee A, Gin T, Chui PT, et al. The accuracy of urinary cotinine immunoassay test strip as an add-on test to self-reported smoking before major elective surgery. Nicotine Tob Res. 2013;15:1690–1695.
Knobloch K, Gohritz A, Meyer-Marcotty M, Vogt PM. Cotinine measurement for postoperative risk stratification in plastic surgery. Plast Reconstr Surg. 2008;122:1587–1588.
Ziegler UE, Kauczok J, Dietz UA, Reith HB, Schmidt K. Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay. Pharmacology 2004;72:254–259.
Delaunay F, Coquerel-Beghin D, Magalon G, et al. A preoperative cotininury test for abdominoplasty reduces peri-operative complications. Ann Chir Plast Esthet. 2018;63:307–315.
Reinbold C, Rausky J, Binder JP, Revol M. Urinary cotinine testing as pre-operative assessment of patients undergoing free flap surgery. Ann Chir Plast Esthet. 2015;60:e51–e57.
Bender D, Haubruck P, Boxriker S, Korff S, Schmidmaier G, Moghaddam A. Validity of subjective smoking status in orthopedic patients. Ther Clin Risk Manag. 2015;11:1297–1303.
Gormsen J, Hjørne F, Helgstrand F. Cotinine test in evaluating smoking cessation at the day of bariatric surgery. Scand J Surg. 2020;109:265–268.
United States Census Bureau. QuickFacts: Bronx County, New York. Available at: https://www.census.gov/quickfacts/fact/table/bronxcountynewyork/PST045221 . Accessed March 19, 2023.
Quest Diagnostics. Test directory: nicotine and cotinine, urine. Available at: https://testdirectory.questdiagnostics.com/test/test-detail/90646/nicotine-and-cotinine-urine?cc=MASTER . Accessed March 19, 2023.
Teven CM, Song DH. Times are a changin’: marijuana use among plastic surgery patients. Plast Reconstr Surg. 2021;148:702e–704e.
Huson HB, Granados TM, Rasko Y. Surgical considerations of marijuana use in elective procedures. Heliyon 2018;4:e00779.
Cone JD Jr, Harrington MA, Kelley SS, Prince MD, Payne WG, Smith DJ Jr. Drug abuse in plastic surgery patients: optimizing detection and minimizing complications. Plast Reconstr Surg. 2011;127:445–455.
D’Antonio ND, Lambrechts MJ, Heard JC, et al. The effect of preoperative marijuana use on surgical outcomes, patient-reported outcomes, and opioid consumption following lumbar fusion. Global Spine J. 2022;14:568–576.
Diggins A, Heinberg L. Marijuana and bariatric surgery. Curr Psychiatry Rep. 2021;23:10.
Anderson SR, Wimalawansa SM, Markov NP, Fox JP. Cannabis abuse or dependence and post-operative outcomes after appendectomy and cholecystectomy. J Surg Res. 2020;255:233–239.
Centers for Disease Control & Prevention. Cannabis facts and stats. Published April 22, 2022. Available at: https://www.cdc.gov/cannabis/data-research/facts-stats . Accessed March 25, 2023.
NYC Smoke Free. Smoking Statistics. Published August 6, 2020. Available at: https://nycsmokefree.org/resources/smoking-statistics . Accessed March 25, 2023.
Rohrich RJ, Coberly DM, Krueger JK, Brown SA. Planning elective operations on patients who smoke: survey of North American plastic surgeons. Plast Reconstr Surg. 2002;109:350–355; discussion 356.
Watson CV, Alexander DS, Oliver BE, Trivers KF. Substance use among adult marijuana and nicotine e-cigarette or vaping product users, 2020. Addict Behav. 2022;132:107349.
Nguyen N, Barrington-Trimis JL, Urman R, et al. Past 30-day co-use of tobacco and marijuana products among adolescents and young adults in California. Addict Behav. 2019;98:106053.
Zielińska-Danch W, Wardas W, Sobczak A, Szołtysek-Bołdys I. Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers 2007;12:484–496.
Sharma P, Sane N, Anand SD, Marimutthu P, Benegal V. Assessment of cotinine in urine and saliva of smokers, passive smokers, and nonsmokers: method validation using liquid chromatography and mass spectrometry. Indian J Psychiatry 2019;61:270–276.
Bartsch RH, Weiss G, Kästenbauer T, et al. Crucial aspects of smoking in wound healing after breast reduction surgery. J Plast Reconstr Aesthet Surg. 2007;60:1045–1049.
Bottorff JL, Seaton CL, Lamont S. Patients’ awareness of the surgical risks of smoking: Implications for supporting smoking cessation. Can Fam Physician 2015;61:e562–e569.
Roter DL, Rudd RE, Comings J. Patient literacy: a barrier to quality of care. J Gen Intern Med. 1998;13:850–851.
Bover Manderski MT, Steinberg MB, Wackowski OA, Singh B, Young WJ, Delnevo CD. Persistent misperceptions about nicotine among US physicians: results from a randomized survey experiment. Int J Environ Res Public Health 2021;18:7713.
Villanti AC, Naud S, West JC, et al. Prevalence and correlates of nicotine and nicotine product perceptions in U.S. young adults, 2016. Addict Behav. 2019;98:106020.
Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023;48:97–117.
Krueger JK, Rohrich RJ. Clearing the smoke: the scientific rationale for tobacco abstention with plastic surgery. Plast Reconstr Surg. 2001;108:1063–1073; discussion 1074.
Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014;2014:CD002294.
Toyoda Y, Fu RH, Li L, Otterburn DM, Rohde CH. Smoking as an independent risk factor for postoperative complications in plastic surgical procedures: a propensity score-matched analysis of 36,454 patients from the NSQIP database from 2005 to 2014. Plast Reconstr Surg. 2018;141:226–236.
Sørensen LT. Wound healing and infection in surgery: the clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147:373–383.
Marin VP, Pytynia KB, Langstein HN, Dahlstrom KR, Wei Q, Sturgis EM. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008;121:451–457.
Chan LKW, Withey S, Butler PEM. Smoking and wound healing problems in reduction mammaplasty: is the introduction of urine nicotine testing justified? Ann Plast Surg. 2006;56:111–115.
Rau AS, Reinikovaite V, Schmidt EP, Taraseviciene-Stewart L, Deleyiannis FWB. Electronic cigarettes are as toxic to skin flap survival as tobacco cigarettes. Ann Plast Surg. 2017;79:86–91.
Troiano C, Jaleel Z, Spiegel JH. Association of electronic cigarette vaping and cigarette smoking with decreased random flap viability in rats. JAMA Facial Plast Surg. 2019;21:5–10.
Knackstedt R, Wu S, Gurunluoglu R. The impact of recreational cannabinoids on peri-operative outcomes. J Plast Reconstr Aesthet Surg. 2020;73:184–199.
Prince MA, Conner BT, Pearson MR. Quantifying cannabis: a field study of marijuana quantity estimation. Psychol Addict Behav. 2018;32:426–433.